SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-002208
Filing Date
2020-02-13
Accepted
2020-02-13 15:22:29
Documents
33
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 246437
2 ex31-1.htm EX-31.1 18547
3 ex32-1.htm EX-32.1 6080
  Complete submission text file 0001493152-20-002208.txt   1028459

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE lwel-20191231.xml EX-101.INS 100403
5 XBRL SCHEMA FILE lwel-20191231.xsd EX-101.SCH 13803
6 XBRL CALCULATION FILE lwel-20191231_cal.xml EX-101.CAL 18124
7 XBRL DEFINITION FILE lwel-20191231_def.xml EX-101.DEF 38246
8 XBRL LABEL FILE lwel-20191231_lab.xml EX-101.LAB 90618
9 XBRL PRESENTATION FILE lwel-20191231_pre.xml EX-101.PRE 78685
Mailing Address 303 WYMAN STREET SUITE 300 WALTHAM MA 02451
Business Address 303 WYMAN STREET SUITE 300 WALTHAM MA 02451 1(781)728 0007
Luckwel Pharmaceuticals Inc. (Filer) CIK: 0001567098 (see all company filings)

IRS No.: 461660653 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 333-187874 | Film No.: 20609881
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences